Español
Català
English

INVESTMENTS IN THE TIMES OF #COVID19

Every crisis brings risks and opportunities to the table… here’s a mind map on how SARS-CoV-2 can impact the activities and value chain of the life sciences VC industry

#quick_notes_LP

ORPHAN DRUGS

Most rare diseases still lack approved treatments despite major advances in the knowledge of their molecular basis. Here’s a map of the different therapeutic modalities plus an update on some of the most interesting new developments in each field.

#quick_notes_LP

SARS-CoV-2

The vaccine effort for #COVID19 is unprecedented in scale & speed. To get it right and fast we need new tools and strategies including DNA/RNA vaccines, virus-like particles, T-cell inducing peptides & viral vectors… here’s a map of the leading edge

#quick_notes_LP

Emerging Fields: PROTAC (2)

These protein-slaying drugs can be used to go after targets that drug developers have long considered ‘undruggable’ and may become the next blockbuster therapies… The gold rush is on! here are some areas of research.

#quick_notes_LP

Fighting rare diseases

A strategic map to fight rare diseases (resulting from a defective gene)… in medicine there are no outliers, no circumstances rare enough to be ignored; every disease, no matter how rare, needs our attention.

#rarediseases #quick_notes_LP

Cell & Gene Therapies

Hundreds of trials are underway with some major therapeutic breakthroughs… Will their use become ubiquitous? Or will its adoption be slow? Here’s a map of the things that matter when discussing CMC issues to develop an advanced therapy.

#quick_notes_LP



TOP